Evidence map›Paper›PMID 28508350›Full record

ReviewCurrent cardiology reports2017

Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.

Paco E Bravo, Sharmila Dorbala

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Preclinical and preliminary clinical evaluation of [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  3. ESC heart failure · 2022
    Review
  4. Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  5. Review
  6. Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Review
  7. The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Review
  8. Amyloidosis in Heart Failure.Current heart failure reports · 2019
    Review
  9. Nuclear imaging of cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  10. Novel Approaches for the Management of AL Amyloidosis.Current hematologic malignancy reports · 2018
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Paco E BravoDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, the Noninvasive Cardiovascular Imaging Program, Departments of Medicine (Cardiology) and Radiology, Cardiac Amyloidosis Program, Department of Medicine, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA.
Sharmila DorbalaDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology, the Noninvasive Cardiovascular Imaging Program, Departments of Medicine (Cardiology) and Radiology, Cardiac Amyloidosis Program, Department of Medicine, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA. sdorbala@partners.org.
Brigham and Women's Hospital · US

Funding

Noninvasive Cardiovascular Imaging Research Training ProgramT32HL094301 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Marcelo F DI CARLI · 2010 to 2026
$7.8M
Molecular Imaging of Primary Amyloid CardiomyopathyR01HL130563 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DORBALA, SHARMILA, FALK, RODNEY H · 2016 to 2019
$3.3M
NHLBI NIH HHS R01 HL130563NHLBI NIH HHS T32 HL094301
6 · The paper itself

Abstract

purpose of reviewThe aim of the present manuscript is to review the latest advancements of radionuclide molecular imaging in the diagnosis and prognosis of individuals with cardiac amyloidosis. RECENT

findings

Indexed as

Amyloid Neuropathies, FamilialAmyloidosisCardiomyopathiesHeartHumansPrognosisRadiopharmaceuticalsTechnetium Tc 99m MedronateRadiopharmaceuticalsTechnetium Tc 99m MedronateAmyloidosisDiagnosisLight chain amyloidosisMolecular imagingPrognosisRadionuclide imagingTransthyretin amyloidosis

Identifiers

PMID28508350
OpenAlexW2616307376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.